Vuopio-Varkila J, Karvonen M, Saxén H
National Public Health Institute, Helsinki, Finland.
J Med Microbiol. 1988 Feb;25(2):77-84. doi: 10.1099/00222615-25-2-77.
Antibody-mediated protection was studied in an experimental murine model of peritonitis-septicaemia with Escherichia coli O18:K1. Protection from lethal intraperitoneal challenge was achieved by passive immunisation with horse anti-K1 capsular antiserum (H46) or rabbit antiserum to the homologous O18 antigen. The maximum increase in LD50 achieved with anti-K1 and anti-O18 antibodies was 10- and 5-fold, respectively. The protective capacity of the anti-O serum was found to be in the IgG fraction. Rabbits were also immunised with various semi-purified or purified outer-membrane-protein preparations (porins and OmpA protein) from rough E. coli or Salmonella strains or with whole E. coli J5 bacteria. Although this immunisation resulted in high antibody titres to homologous and, to a lesser extent, also to heterologous antigens, none of the antisera protected against challenge with the capsulate E. coli O18:K1 bacteria.
在大肠杆菌O18:K1引起的腹膜炎-败血症实验小鼠模型中研究了抗体介导的保护作用。用马抗K1荚膜抗血清(H46)或兔抗同源O18抗原血清进行被动免疫,可实现对致死性腹腔内攻击的保护。抗K1和抗O18抗体使半数致死剂量(LD50)的最大增加倍数分别为10倍和5倍。发现抗O血清的保护能力存在于IgG组分中。还用来自粗糙型大肠杆菌或沙门氏菌菌株的各种半纯化或纯化的外膜蛋白制剂(孔蛋白和OmpA蛋白)或完整的大肠杆菌J5细菌对兔子进行免疫。尽管这种免疫导致针对同源抗原以及在较小程度上针对异源抗原产生高抗体滴度,但没有一种抗血清能保护小鼠免受荚膜型大肠杆菌O18:K1细菌的攻击。